Please use this identifier to cite or link to this item: http://dl.umsu.ac.ir/handle/Hannan/27089
Title: A Guanidine-rich Regulatory Oligodeoxynucleotide Improves Type-2 Diabetes in Obese Mice by Blocking T-cell Differentiation
Authors: Cheng, Xiang;Wang, Jing;Xia, Ni;Yan, Xin-Xin;Tang, Ting-Ting;Chen, Han;Zhang, Hong-Jian;Liu, Juan;Kong, Wen;Sjöberg, Sara;Folco, Eduardo;Libby, Peter;Liao, Yu-Hua;Shi, Guo-Ping
subject: macrophage;Obesity;regulatory oligodeoxynucleotide;T-cell differentiation;type-2 diabetes
Year: 2012
Publisher: WILEY-VCH Verlag
Description: T lymphocytes exhibit pro-inflammatory or anti-inflammatory activities in obesity and diabetes, depending on their subtypes. Guanidine-rich immunosuppressive oligodeoxynucleotides (ODNs) effectively control Th1/Th2-cell counterbalance. This study reveals a non-toxic regulatory ODN (ODNR01) that inhibits Th1- and Th17-cell polarization by binding to STAT1/3/4 and blocking their phosphorylation without affecting Th2 and regulatory T cells. ODNR01 improves glucose tolerance and insulin sensitivity in both diet-induced obese (DIO) and genetically generated obese (ob/ob) mice. Mechanistic studies show that ODNR01 suppresses Th1- and Th17-cell differentiation in white adipose tissue, thereby reducing macrophage accumulation and M1 macrophage inflammatory molecule expression without affecting M2 macrophages. While ODNR01 shows no effect on diabetes in lymphocyte-free Rag1-deficient DIO mice, it enhances glucose tolerance and insulin sensitivity in CD4\(^+\) T-cell-reconstituted Rag1-deficient DIO mice, suggesting its beneficial effect on insulin resistance is T-cell-dependent. Therefore, regulatory ODNR01 reduces obesity-associated insulin resistance through modulation of T-cell differentiation.
URI: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491840/pdf/
http://nrs.harvard.edu/urn-3:HUL.InstRepos:10589815
Standard no: Cheng, Xiang, Jing Wang, Ni Xia, Xin-Xin Yan, Ting-Ting Tang, Han Chen, Hong-Jian Zhang, et al. 2012. A guanidine-rich regulatory oligodeoxynucleotide improves type-2 diabetes in obese mice by blocking T-cell differentiation. EMBO Molecular Medicine 4(10): 1112-1125.
1757-4676
Appears in Collections:HMS Scholarly Articles

Files in This Item:
Click on the URI links for accessing contents.


Items in HannanDL are protected by copyright, with all rights reserved, unless otherwise indicated.